Sign Up Today and Learn More About Finch Therapeutics Group Stock
Invest in or calculate the value of your shares in Finch Therapeutics Group or other pre-IPO companies through EquityZen's platform.
Finch Therapeutics Group Stock
Finch Therapeutics Group is a microbiome therapeutics company, develops microbial therapies serving patients with serious.
About Finch Therapeutics Group Stock
Founded
2004
Headquarters
Somerville, MA, US
Total Funding
41.6M
Industries
Software, Artificial Intelligence, Data and Analytics
Finch Therapeutics, a mission-driven microbiome engineering company, is developing novel microbial therapies to serve patients with serious and unmet medical needs. Founded by data scientists, clinicians, and microbiologists from MIT and OpenBiome, Finch uses machine- learning algorithms informed by high-throughput molecular data to reverse engineer successful clinical experience with fecal transplantation.
Finch Therapeutics Group Management
Leadership team at Finch Therapeutics Group
CEO
MARK SMITH
CFO
Greg Perry
Join now and verify your accreditation status to gain access to:
- Finch Therapeutics Group current valuation
- Finch Therapeutics Group stock price
- Available deals in Finch Therapeutics Group and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Finch Therapeutics Group stock?
Accredited investors can buy pre-IPO stock in companies like Finch Therapeutics Group through EquityZen funds. These investments are made available by existing Finch Therapeutics Group shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Finch Therapeutics Group stock?
Shareholders can sell their Finch Therapeutics Group stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
